Lung transplantation in children with idiopathic pulmonary arterial hypertension
Authors:
- Astrid E. LammersALAstrid E. Lammers
- Michael BurchMBMichael Burch
- Martin J. ElliottMEMartin J. Elliott
- Philip ReesPRPhilip Rees
- Sheila G. HaworthSHSheila G. Haworth
- Paul AuroraPAPaul Aurora
- 9 February 2010
- journal article
- research article
- Published by Wiley in Pediatric Pulmonology
- Vol. 45 (3) , 263-269
Abstract
Background Despite improved medical therapy, transplantation (Tx) represents the only option for end-stage pulmonary vascular disease. Methods Clinical data of children with idiopathic pulmonary arterial hypertension (IPAH) referred for Tx assessment between January 2002 and June 2007 were related to listing decision and outcome. Results Seven of the 14 children assessed for Tx were listed. Five were transplanted (lung Tx, n = 3; heart–lung Tx, n = 2) and two died on the waiting list. Mean age at diagnosis was 3.7 (0.4–9.5) years. Time from diagnosis to listing was 3.6 years (range 1.4–9.3). Children listed were in a worse functional class (WHO 3.5 vs. 2.5; P = 0.0006), had a lower SpO2 on exercise (76.5% vs. 89%; P = 0.0001) and a shorter 6-min walk distance (154 m vs. 330 m; P < 0.01) than those not listed. Right ventricular function was worse in those listed (P = 0.03), as was pulmonary vascular resistance index (PVRI) on vasodilator testing (34 U m2 vs. 14.6 U m2; P = 0.03). Age at diagnosis and at assessment, weight, height, mean pulmonary artery pressure, baseline PVRI, B-type natriuretic peptide, spirometry and resting-SO2 did not differ between the two groups. For the five children transplanted, median waiting time was 81 days. Age at Tx was 5.4 years. After 2.8 years all transplanted children are alive with a good functional outcome. Two patients died on the active waiting list. All children considered too well for listing are still alive and stable on treatment. Conclusions Outcome after transplantation in children with IPAH has been encouraging. Defining listing criteria for these patients remains a challenge. Pediatr Pulmonol. 2010; 45:263–269.Keywords
This publication has 27 references indexed in Scilit:
- Registry of the International Society for Heart and Lung Transplantation: Tenth Official Pediatric Lung and Heart/Lung Transplantation Report—2007The Journal of Heart and Lung Transplantation, 2007
- International Guidelines for the Selection of Lung Transplant Candidates: 2006 Update—A Consensus Report From the Pulmonary Scientific Council of the International Society for Heart and Lung TransplantationThe Journal of Heart and Lung Transplantation, 2006
- Transplantation as a treatment for end-stage pulmonary hypertension in childhoodPaediatric Respiratory Reviews, 2006
- Preliminary Experience With Bosentan as Initial Therapy in Childhood Idiopathic Pulmonary Arterial HypertensionThe Journal of Heart and Lung Transplantation, 2006
- Paediatric lung transplantationEuropean Respiratory Journal, 2004
- Outcomes in Children With Idiopathic Pulmonary Arterial HypertensionCirculation, 2004
- Survival in Primary Pulmonary HypertensionCirculation, 2002
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Survival in Patients with Primary Pulmonary HypertensionAnnals of Internal Medicine, 1991
- Primary Pulmonary HypertensionAnnals of Internal Medicine, 1987